Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
DOI

10.1016/j.jaip.2019.03.010

Type

Journal article

Journal

The journal of allergy and clinical immunology. In practice

Publication Date

05/2019

Volume

7

Pages

1430 - 1436

Addresses

Respiratory Medicine Unit and Oxford Respiratory NIHR BRC, Nuffield Department of Medicine, University of Oxford, Oxford, UK. Electronic address: ian.pavord@ndm.ox.ac.uk.

Keywords

Humans, Asthma, Eosinophilia, Nitric Oxide, Immunoglobulin E, Anti-Asthmatic Agents, Interleukin-5, Vital Capacity, Peak Expiratory Flow Rate, Forced Expiratory Volume, Administration, Inhalation, Severity of Illness Index, Respiration, Middle Aged, Male, Receptors, Interleukin-5, Interleukin-4 Receptor alpha Subunit, Antibodies, Monoclonal, Humanized, Omalizumab, Clinical Decision-Making, Fluticasone-Salmeterol Drug Combination